FDA NDC Directory · JSON-LD · Markdown

Adalimumab-bwwd

NDC 83457-186 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic nameadalimumab-bwwd
Labeler / ManufacturerCordavis Limited
Marketing categoryBiologic License Application · App BLA761059
Dosage form / routeSOLUTION · SUBCUTANEOUS
Active ingredientsADALIMUMAB (40 mg/.4mL)
Marketing started20251212
Package count1

External sources

Source: openFDA. Public-domain (CC0).